Which Factors Determine the Success of Anticoagulation with Warfarin

Akif Bayyigit, Mustafa Genco Erdem, Erdal Belen, Mehmet Kucuk
{"title":"Which Factors Determine the Success of Anticoagulation with Warfarin","authors":"Akif Bayyigit, Mustafa Genco Erdem, Erdal Belen, Mehmet Kucuk","doi":"10.5812/intjcardiovascpract-140879","DOIUrl":null,"url":null,"abstract":"Background: Warfarin is a drug most commonly used for anticoagulation. Its efficiency depends on remaining in the demanded therapeutic range. Objectives: In this study, the relation between the time in therapeutic range (TTR) and sociodemographic characteristics, comorbidities, and drugs used was investigated for the patient’s use of warfarin. Methods: Among patients admitted to the Internal Diseases Polyclinic or taking inpatient treatment in internal diseases service, 50 female and 50 male patients using warfarin were selected starting from the closest date based on their admittance dates. Using patient files and hospital automation system data, TTR levels were calculated with the Rosendaal method, and sociodemographic characteristics, comorbidities, and drugs used were recorded. Patients were separated into 2 groups, TTR > 60% and TTR < 60%, and relations between sociodemographic characteristics, comorbidities, and drugs used were investigated among these groups. Results: Time in therapeutic range was found to be over 60% in 34% of the patients. It was observed that gender, occupation and education level, body mass index, smoking ratios, comorbid diseases, drugs used, serum creatinine, and alanine aminotransferase (ALT) levels were similar among TTR groups. The use of drugs lowering the warfarin effect was found to be similar among TTR groups. Conclusions: It was observed that sociodemographic characteristics, comorbid diseases, used drugs, serum creatinine, and ALT levels of the patients didn't affect the time in the therapeutic range.","PeriodicalId":31436,"journal":{"name":"International Journal of Cardiovascular Practice","volume":"4 4","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cardiovascular Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5812/intjcardiovascpract-140879","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Warfarin is a drug most commonly used for anticoagulation. Its efficiency depends on remaining in the demanded therapeutic range. Objectives: In this study, the relation between the time in therapeutic range (TTR) and sociodemographic characteristics, comorbidities, and drugs used was investigated for the patient’s use of warfarin. Methods: Among patients admitted to the Internal Diseases Polyclinic or taking inpatient treatment in internal diseases service, 50 female and 50 male patients using warfarin were selected starting from the closest date based on their admittance dates. Using patient files and hospital automation system data, TTR levels were calculated with the Rosendaal method, and sociodemographic characteristics, comorbidities, and drugs used were recorded. Patients were separated into 2 groups, TTR > 60% and TTR < 60%, and relations between sociodemographic characteristics, comorbidities, and drugs used were investigated among these groups. Results: Time in therapeutic range was found to be over 60% in 34% of the patients. It was observed that gender, occupation and education level, body mass index, smoking ratios, comorbid diseases, drugs used, serum creatinine, and alanine aminotransferase (ALT) levels were similar among TTR groups. The use of drugs lowering the warfarin effect was found to be similar among TTR groups. Conclusions: It was observed that sociodemographic characteristics, comorbid diseases, used drugs, serum creatinine, and ALT levels of the patients didn't affect the time in the therapeutic range.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
哪些因素决定华法林抗凝成功
背景:华法林是一种最常用的抗凝药物。它的有效性取决于保持在所需的治疗范围内。目的:本研究探讨华法林患者的治疗范围内时间(TTR)与社会人口学特征、合并症和用药之间的关系。方法:在内科综合门诊住院或内科门诊住院的患者中,根据患者入院日期,从最近的日期开始选择使用华法林的患者,女性50例,男性50例。利用患者档案和医院自动化系统数据,采用Rosendaal方法计算TTR水平,并记录社会人口学特征、合并症和药物使用情况。患者分为两组,TTR组和gt组;60%和TTR <60%,并调查了这些群体的社会人口学特征、合并症和药物使用之间的关系。结果:34%的患者停留在治疗范围内的时间超过60%。观察TTR组患者的性别、职业及受教育程度、体重指数、吸烟比例、合并症、用药情况、血清肌酐、丙氨酸转氨酶(ALT)水平相似。在TTR组中,使用降低华法林效应的药物的情况相似。结论:观察到患者的社会人口学特征、合并症、用药、血清肌酐、ALT水平在治疗范围内对时间无影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
4
审稿时长
8 weeks
期刊最新文献
Evaluating and Comparing Expression Levels of miR-199a and miR-126 in Peripheral Blood of Patients with Lone Atrial Fibrillation and Healthy Controls The Rising Burden of Cardiovascular Diseases in Somalia: Causes and Solutions The Role of Coronary CT Angiography in Chronic Total Occlusion Coronary Intervention Novel Issues in the Treatment of Heart Failure, Based on the European Society of Cardiology (ESC) 2023 Congress Bioresorbable Vascular Scaffolds: Should We use Them Again?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1